There's no evidence to say that there's a manufacturing problem only you clutching at straws with JCR and you don't know what's going on behind closed doors with Lonza or any other company that they might be striking a deal with.
You rant on about being a 2 bill company which in the grand scheme of things is peanuts compared to the potential MC.
MSB is by far the most advanced in this space.
Ask yourself why CYP have gone straight to P3 because there is a whole lot of evidence pointing towards positive data in this space, with MSB being a front runner the rest will come along for the ride.
You know what they say first in best dressed
MSB Trading - 2020, page-16684
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.005(0.39%) |
Mkt cap ! $1.467B | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.27 | $1.653M | 1.285M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16781 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 9777 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |